5v4x
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='5v4x' size='340' side='right' caption='[[5v4x]], [[Resolution|resolution]] 2.08Å' scene=''> | <StructureSection load='5v4x' size='340' side='right' caption='[[5v4x]], [[Resolution|resolution]] 2.08Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5v4x]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5V4X OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5V4X FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5v4x]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5V4X OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5V4X FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=8WJ:(2S)-3-cyclohexyl-2-[4-(cyclopentylsulfonyl)-2-oxopyridin-1(2H)-yl]-N-(1,3-thiazol-2-yl)propanamide'>8WJ</scene>, <scene name='pdbligand=GLC:ALPHA-D-GLUCOSE'>GLC</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=8WJ:(2S)-3-cyclohexyl-2-[4-(cyclopentylsulfonyl)-2-oxopyridin-1(2H)-yl]-N-(1,3-thiazol-2-yl)propanamide'>8WJ</scene>, <scene name='pdbligand=GLC:ALPHA-D-GLUCOSE'>GLC</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5v4w|5v4w]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5v4w|5v4w]]</td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">GCK ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glucokinase Glucokinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 2.7.1.2] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glucokinase Glucokinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 2.7.1.2] </span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5v4x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5v4x OCA], [http://pdbe.org/5v4x PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5v4x RCSB], [http://www.ebi.ac.uk/pdbsum/5v4x PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5v4x ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5v4x FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5v4x OCA], [http://pdbe.org/5v4x PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5v4x RCSB], [http://www.ebi.ac.uk/pdbsum/5v4x PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5v4x ProSAT]</span></td></tr> | ||
| Line 27: | Line 28: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Glucokinase]] | [[Category: Glucokinase]] | ||
| + | [[Category: Human]] | ||
[[Category: Hosfiled, D J]] | [[Category: Hosfiled, D J]] | ||
[[Category: Skene, R J]] | [[Category: Skene, R J]] | ||
Revision as of 10:29, 22 November 2017
Human glucokinase in complex with novel pyrazole activator.
| |||||||||||
